// App-Quantinova.ai

e14551 : Evaluation of baseline asymptomatic dysimmunity prevalence in cancer patients receiving monoclonal anti-PD1 antibodies.

Researchers

Presenter

  • Jennifer ARRONDEAU

Principal Investigators

  • Pascaline Boudou-Rouquette

  • Claire Goulvestre

  • Olivier Huillard

  • Nora Kramkimel

  • Jeanne Chapron

  • Camille Tlemsani

  • Anne Jouinot

  • Marco Alifano

  • Audrey Mansuet-Lupo

  • Diane Damotte

  • Jerome Alexandre

  • Francois Goldwasser

  • Frederic Batteux

Medical Centers

  • Department of Pharmacokinetics and Pharmacochemistry, Cochin Hospital, Paris Descartes University, AP-HP, CARPEM, Immunomodulatory Therapies Multidisciplinary Study group (CERTIM), Paris, France

  • Department of Immunology, Cochin Hospital, Paris Descartes University, Immunomodulatory Therapies Multidisciplinary Study group (CERTIM), Paris, France, Paris, France

  • Department of Pharmacokinetics and Pharmacochemistry, Cochin Hospital, Paris Descartes University, AP-HP, CARPEM, Immunomodulatory Therapies Multidisciplinary Study group (CERTIM), Paris, France

  • Department of Pharmacokinetics and Pharmacochemistry, Cochin Hospital, Paris Descartes University, AP-HP, CARPEM, Immunomodulatory Therapies Multidisciplinary Study group (CERTIM), Paris, France

  • Department of Pharmacokinetics and Pharmacochemistry, Cochin Hospital, Paris Descartes University, AP-HP, CARPEM, Immunomodulatory Therapies Multidisciplinary Study group (CERTIM), Paris, France

  • Department of Pharmacokinetics and Pharmacochemistry, Cochin Hospital, Paris Descartes University, AP-HP, CARPEM, Immunomodulatory Therapies Multidisciplinary Study group (CERTIM), Paris, France

  • Department of Immunology, Cochin Hospital, Paris Descartes University, Immunomodulatory Therapies Multidisciplinary Study group (CERTIM), Paris, France, Paris, France

  • Department of Pharmacokinetics and Pharmacochemistry, Cochin Hospital, Paris Descartes University, AP-HP, CARPEM, Immunomodulatory Therapies Multidisciplinary Study group (CERTIM), Paris, France

  • Department of Pharmacokinetics and Pharmacochemistry, Cochin Hospital, Paris Descartes University, AP-HP, CARPEM, Immunomodulatory Therapies Multidisciplinary Study group (CERTIM), Paris, France

  • Department of Pharmacokinetics and Pharmacochemistry, Cochin Hospital, Paris Descartes University, AP-HP, CARPEM, Immunomodulatory Therapies Multidisciplinary Study group (CERTIM), Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved